To explore the ability of the three candidate genes as potential biomarkers to distinguish between ICH patients and other groups, we detected the expression levels of CKAP4, BCL6 and TLR8 in ICH patients, IS patients, HTN controls and CTRLs as FPKM values in both cohorts. Here, TLR8 is linked to hypertensive disorder.